These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 8761294)
1. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells. Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294 [TBL] [Abstract][Full Text] [Related]
2. Transformation suppressor activity of C3G is independent of its CDC25-homology domain. Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a protein kinase C-delta (PKC-delta) ATP binding mutant. An inactive enzyme that competitively inhibits wild type PKC-delta enzymatic activity. Li W; Yu JC; Shin DY; Pierce JH J Biol Chem; 1995 Apr; 270(14):8311-8. PubMed ID: 7713939 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells. Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899 [TBL] [Abstract][Full Text] [Related]
5. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts. Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism. Arai H; Escobedo JA Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase C-epsilon associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity. Ueffing M; Lovrić J; Philipp A; Mischak H; Kolch W Oncogene; 1997 Dec; 15(24):2921-7. PubMed ID: 9416835 [TBL] [Abstract][Full Text] [Related]
9. smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells. Sakoda T; Kaibuchi K; Kishi K; Kishida S; Doi K; Hoshino M; Hattori S; Takai Y Oncogene; 1992 Sep; 7(9):1705-11. PubMed ID: 1323817 [TBL] [Abstract][Full Text] [Related]
10. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway. Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of the p72-74 RAF-1 kinase in 3T3 fibroblasts expressing ras or src oncogenes. Reed JC; Yum S; Cuddy MP; Turner BC; Rapp UR Cell Growth Differ; 1991 May; 2(5):235-43. PubMed ID: 1888699 [TBL] [Abstract][Full Text] [Related]
13. Protein kinase C-stimulated formation of ethanolamine from phosphatidylethanolamine involves a protein phosphorylation mechanism: negative regulation by p21 Ras protein. Deli E; Kiss Z Arch Biochem Biophys; 2000 May; 377(1):171-7. PubMed ID: 10775457 [TBL] [Abstract][Full Text] [Related]
14. V-sis induces Egr-1 expression by a pathway mediated by c-Ha-Ras. Huang RP; Ngo L; Okamura D; Tucker M; Adamson ED J Cell Biochem; 1994 Dec; 56(4):469-79. PubMed ID: 7890805 [TBL] [Abstract][Full Text] [Related]
15. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Kolch W; Heidecker G; Kochs G; Hummel R; Vahidi H; Mischak H; Finkenzeller G; Marmé D; Rapp UR Nature; 1993 Jul; 364(6434):249-52. PubMed ID: 8321321 [TBL] [Abstract][Full Text] [Related]
16. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018 [TBL] [Abstract][Full Text] [Related]
17. Truncated, desensitization-defective neurokinin receptors mediate sustained MAP kinase activation, cell growth and transformation by a Ras-independent mechanism. Alblas J; van Etten I; Moolenaar WH EMBO J; 1996 Jul; 15(13):3351-60. PubMed ID: 8670836 [TBL] [Abstract][Full Text] [Related]
19. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling. Villalonga P; López-Alcalá C; Bosch M; Chiloeches A; Rocamora N; Gil J; Marais R; Marshall CJ; Bachs O; Agell N Mol Cell Biol; 2001 Nov; 21(21):7345-54. PubMed ID: 11585916 [TBL] [Abstract][Full Text] [Related]
20. C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth. Guerrero C; Martín-Encabo S; Fernández-Medarde A; Santos E Oncogene; 2004 Jun; 23(28):4885-93. PubMed ID: 15077165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]